Melanoma: for the treatment of patients with unresectable or metastatic melanoma
Dose
100 mg /4 ml
Dosage
100mg Injection
Country of Origin
Made in India
Manufacture
Ziska Pharma
KEYTRUDA 100MG
₹ 34,566 / Vial
Keytruda 100mg (pembrolizumab) is a prescription immunotherapy injection used to treat various advanced cancers, including melanoma, non-small cell lung cancer, head and neck cancer, Hodgkin lymphoma, and urothelial carcinoma. It acts as a PD-1 inhibitor, blocking specific receptors to enhance the immune systems ability to destroy cancer cells.